BIOLOGICAL · Unmapped registry intervention
MASCT-I
Find medicine records ·
Find other trials using this name
Clinical trial
A Phase I Clinical Study for Evaluating the Safety of MASCT-I in Advanced Soild Tumor
NCT03393416
Drugs and interventions used in this trial
2 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
DRUG · Unmapped registry intervention
PD1 antibody
Find medicine records ·
Find other trials using this name
No matching interventions in this trial.
Study at a glance
Registry-backedA Phase I Clinical Study for Evaluating the Safety of MASCT-I in Advanced Soild Tumor
Design: INTERVENTIONAL · Status: UNKNOWN · Phase: PHASE1
Read study objectives, eligibility and outcome measures at ClinicalTrials.govAdvertisement
Conditions
Advanced Gastric Cancerunresolved
Interventions
MASCT-IBIOLOGICAL
PD1 antibodyDRUG
Sponsors & collaborators
HRYZ Biotech Co.lead sponsor
Peking University Cancer Hospital & Institutecollaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT03393416 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.